Deep brain stimulation study for Parkinson's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial studies how deep brain stimulation (DBS) works and can help control Parkinson's symptoms. It uses a special DBS device that is safe for MRI scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 50 and 70 years old.
- You have typical Parkinson's disease and have had it for less than 20 years.
- You are planning to get a specific brand of DBS device (G106R or G106RS) for brain surgery.
- Your thinking and memory are fairly good (no severe dementia).
- You can see and hear well enough to follow instructions and complete tasks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an approach to improving Parkinson’s symptoms in people who already have deep brain stimulation (DBS) devices. It focuses on patients who are able to do walking tests safely and confirm they can understand and consent.
This study tests a new type of deep brain stimulation (DBS)—a surgical treatment that uses electrical pulses to help control Parkinson's symptoms. Unlike standard DBS, this system adapts automatically to your body's needs. You may qualify if you've never had DBS surgery or if you've had it before and are willing to switch to the new device.
This study looks at factors that predict how well deep brain stimulation (DBS) works for people with Parkinson's disease. If you are considering DBS, joining this research could help doctors better understand who benefits most from the procedure.
This study looks at how deep brain stimulation (an implanted brain device) affects Parkinson’s symptoms, especially movement problems like freezing, slowness, or involuntary movements. It may help people whose symptoms are not fully controlled by standard Parkinson medicines.
This study looks at how deep brain stimulation (DBS) in a part of the brain called the subthalamic nucleus affects Parkinson's disease. It aims to understand the biological changes that happen with this treatment.
This trial tests whether deep brain stimulation (DBS) can help people with early-stage Parkinson's disease. If you have Parkinson's for less than 4 years and your medications work well, this study may help slow the need for higher medication doses.
Hear when a new Parkinson's Disease and Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.